These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 28164387)
1. Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies. Koye DN; Shaw JE; Reid CM; Atkins RC; Reutens AT; Magliano DJ Diabet Med; 2017 Jul; 34(7):887-901. PubMed ID: 28164387 [TBL] [Abstract][Full Text] [Related]
2. Risk Prediction and Management of Chronic Kidney Disease in People Living with Type 2 Diabetes Mellitus. Ooi YG; Sarvanandan T; Hee NKY; Lim QH; Paramasivam SS; Ratnasingam J; Vethakkan SR; Lim SK; Lim LL Diabetes Metab J; 2024 Mar; 48(2):196-207. PubMed ID: 38273788 [TBL] [Abstract][Full Text] [Related]
3. Diabetic renal disease in blacks--inevitable or preventable? Rostand SG N Engl J Med; 1989 Oct; 321(16):1121-2. PubMed ID: 2797070 [No Abstract] [Full Text] [Related]
4. Diagnosis and Management of Type 2 Diabetic Kidney Disease. Doshi SM; Friedman AN Clin J Am Soc Nephrol; 2017 Aug; 12(8):1366-1373. PubMed ID: 28280116 [TBL] [Abstract][Full Text] [Related]
5. Diabetes and chronic kidney disease: an increasingly common multi-morbid disease in need of a paradigm shift in care. Winocour PH Diabet Med; 2018 Mar; 35(3):300-305. PubMed ID: 29247554 [TBL] [Abstract][Full Text] [Related]
12. Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis. Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V Diabetes Obes Metab; 2019 May; 21(5):1237-1250. PubMed ID: 30697905 [TBL] [Abstract][Full Text] [Related]
13. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. GBD Chronic Kidney Disease Collaboration Lancet; 2020 Feb; 395(10225):709-733. PubMed ID: 32061315 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. Major RW; Cheng MRI; Grant RA; Shantikumar S; Xu G; Oozeerally I; Brunskill NJ; Gray LJ PLoS One; 2018; 13(3):e0192895. PubMed ID: 29561894 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and Disease Burden of Chronic Kidney Disease. Lv JC; Zhang LX Adv Exp Med Biol; 2019; 1165():3-15. PubMed ID: 31399958 [TBL] [Abstract][Full Text] [Related]
16. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Anders HJ; Huber TB; Isermann B; Schiffer M Nat Rev Nephrol; 2018 Jun; 14(6):361-377. PubMed ID: 29654297 [TBL] [Abstract][Full Text] [Related]
17. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes. Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570 [TBL] [Abstract][Full Text] [Related]
18. Liraglutide and Renal Outcomes in Type 2 Diabetes. Mann JFE; Ørsted DD; Brown-Frandsen K; Marso SP; Poulter NR; Rasmussen S; Tornøe K; Zinman B; Buse JB; N Engl J Med; 2017 Aug; 377(9):839-848. PubMed ID: 28854085 [TBL] [Abstract][Full Text] [Related]
19. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Krolewski AS; Skupien J; Rossing P; Warram JH Kidney Int; 2017 Jun; 91(6):1300-1311. PubMed ID: 28366227 [TBL] [Abstract][Full Text] [Related]